Clinical Trial

Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study

Completed
View on ClinicalTrials.gov →
Summary
Patient are randomized into 2 groups under computer registered numbers. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-18.
Trial Details
NCT Number NCT07184125
Lead Sponsor Shaukat Khanum Memorial Cancer Hospital & Research Centre
Conditions Anxiety
Enrollment 124 participants
Start Date 2024-08-30
Primary Completion 2025-09-10 (estimated)
Study Completion 2025-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-08